PHAT

Phathom Pharmaceuticals, Inc.

11.20 USD
+0.12 (+1.08%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Phathom Pharmaceuticals, Inc. stock is up 6.67% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 60% of the previous 4 June’s closed higher than May. In the last 4 Unusual Options Trades, there were 4 CALLs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
02 May 14:36 16 Aug, 2024 10.00 CALL 167 464
02 May 14:36 16 Aug, 2024 10.00 CALL 222 464
02 May 14:38 16 Aug, 2024 10.00 CALL 517 464
02 May 14:41 16 Aug, 2024 10.00 CALL 4220 464

About Phathom Pharmaceuticals, Inc.

Phathom Pharmaceuticals, Inc. focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach.

  • Needham
    Fri Jun 14, 08:43
    buy
    confirm
  • Needham
    Fri Jun 7, 08:24
    buy
    confirm
  • Needham
    Fri May 31, 08:24
    buy
    confirm
  • Needham
    Fri May 24, 12:35
    buy
    confirm